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A total of 34439 male British doctors, who reported their smoking habits in November 1951, were followed, with periodic up date
of changes in their habits, until death, emigration, censoring. or November 2001. Information was obtained about their mortality from
28 of the 30 types of cancer in men reviewed by the International Agency for Research on Cancer (no death was recorded from the
other two). In all, 11 of the 13 types in men that the Agency classed as liable to be caused by smoking were significantly related to
smoking and the findings for the other two, which caused only few deaths, suggested they might be. Of the 13 types in men for which
the Agency found only sparse or inconsistent data and for which we had data, only two appeared to be possibly related (one
positively, one negatively), and the 638 deaths for the summed group were clearly unrelated to smoking. Of the two types for which
the Agency thought that the relationship with smoking might be due to bias or confounding, the findings for one (prostate cancer)
tended to support the belief that smoking was unrelated, and those for the other (colorectal cancer) showed a weak relationship with
smoking, which (in a small subset) could not be attributed to confounding with the consumption of alcohol.
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Knowledge of the effect of tobacco smoking in the production of
cancer has increased progressively over 200 years until the
International Agency for Research on Cancer (2004) was able to
conclude that it contributed, to a greater or lesser extent, to the
production of 15 types of the disease. Of the 19 other types that the
Agency reviewed, two were commonly reported to be positively
related to smoking, but the Agency thought that the positive
findings might be attributable to bias in one case (prostate cancer)
and to confounding in the other (colorectal cancer). For one type
of cancer, the evidence showed a negative relationship with
smoking, which indicated a protective effect (endometrial cancer),
while for the other 16, the evidence either indicated no relationship
at all (breast cancer in women) or was inconsistent or sparse
(cancers of the salivary glands, small intestine, gallbladder and bile
ducts, soft-tissue sarcoma, melanoma, other skin cancers, cancers
of the ovary, testis, central nervous system, thyroid, and adrenal,
Hodgkin’s lymphoma, other lymphomas, lymphatic leukaemia,
and myeloma).
In reaching these conclusions, the Agency included inter alia the
published evidence for 14 types of cancer from observations on the
mortality of 34400 male British doctors over 40 years (Doll et al,
1994). Some additional evidence has, however, now been obtained
by following the cohort for a further 10 years and we report here
our observations relating to tobacco smoking over a 50-year
period (1951–2001) for 28 of the 30 types of cancer that occur in
men, which the Agency reviewed. During this period, information
about smoking habits was updated periodically (in 1957, 1966,
1971, 1978, and 1991) with response rates varying between 94
and 98%. A more detailed account of the population and the
methods of follow-up and analysis are described elsewhere (Doll
et al, 2004).
FINDINGS
Cancers liable to be caused by smoking
Table 1 shows the mortality rates in relation to smoking habits of
13 types of cancer in men that the Agency classed as liable to be
caused by smoking. A 14th (cancer of the ureter) was not classed
separately in our data but included with cancer of the bladder.
Table 1 also includes data for cancers of unspecified site, as many
of them are likely to have been one or other of the major types that
are commonly caused by smoking.
Inspection of the table shows that eight of the specified types of
cancer and cancers of unspecified type were all clearly related to
smoking, in that there were statistically significant positive trends
in the mortality rates from lifelong nonsmokers through light and
moderate cigarette smokers to heavy cigarette smokers and from
nonsmokers through ex-smokers to continuing smokers. For one
other type (myeloid leukaemia), there was a significant trend in the
former but not in the latter, and for two others (stomach and
kidney), there were significant trends in the latter but not in the
former. The two remaining types (nasopharyngeal and nasal
cancers) contributed only small numbers of cases (4 and 6,
respectively), but the evidence, such as it is, suggests positive
relationships.
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Table 2 shows comparable data for the two cancers for which the
Agency thought the relationship with smoking might be due to
bias or confounding.
Prostate cancer
The question of bias arose in the Agency’s review because a
positive relationship between smoking and prostate cancer was
seen in many sets of mortality data but not in incidence data.
Prostate cancers tend to occur at older ages than other cancers and
often persist for many years before death. In these circumstances,
it was thought that death that was actually due to (say) intercurrent
pneumonia or vascular disease, both related to smoking, might be
attributed on the death certificate to a prevalent prostate cancer,
thus causing an artificial relationship with smoking that would not
be seen in incidence data. Our data, now based on nearly 900
deaths, show some increasing risk with increasing numbers of
cigarettes smoked per day, but only among smokers; there is no
appreciable difference between nonsmokers and continuing
smokers and the lowest risk is recorded in ex-smokers. They
tend, therefore, to support the idea that smoking is unrelated to the
disease.
Large bowel cancer
Cancers of the large bowel have frequently been related to both
smoking and the consumption of alcohol (Corrao et al, 2004;
International Agency for Research on Cancer, 2004) and, as
smokers tend to be heavier drinkers than nonsmokers, it seemed
possible that the relationship observed with smoking might be an
Table 1 Cause-specific mortality by smoking habit, standardised indirectly for age and study year: cancers related to smoking
Mortality per 100000 per year
Standardised tests
or trend (v
2 on 1df)
a Lifelong
nonsmoker
Cigarette smokers, no other habit Other smokers
Former Current
Current, cigarettes per day
Former Current N/X/S Amount
Type of cancer No. of deaths 1–14 15–24 X25
Oral 43 1.9 1.3 7.1 4.0 3.7 15.9 4.4 6.8 10.32 8.53
Oro- and
hypopharyngeal
34 0.0 1.7 6.7 4.5 0.0 19.4 1.7 7.1 23.38 23.17
Nasopharynx 4 0.0 0.5 0.4 0.0 0.0 1.6 0.7 0.3 0.04 1.74
Nose and nasal sinuses 6 0.5 0.0 1.5 0.0 0.0 4.8 1.1 0.4 0.19 3.18
Larynx 40 0.0 2.6 10.3 6.0 8.5 17.3 2.9 4.7 17.46 25.38
Lung 1052 16.9 68.8 249.0 130.6 233.8 415.2 69.8 129.8 363.47 451.05
Oesophagus 207 5.7 20.1 34.4 21.2 34.4 50.0 18.9 25.1 29.40 37.49
Stomach 324 28.1 25.4 41.9 38.5 47.6 38.8 28.1 37.5 8.75 2.60
Pancreas 272 20.6 30.5 39.4 37.9 31.2 52.9 15.9 32.1 11.93 8.39
Liver 74 4.4 5.7 13.6 10.7 2.6 31.3 8.1 8.3 5.26 9.80
Kidney 140 9.3 13.2 16.2 16.4 16.6 15.5 12.1 18.2 6.92 1.61
Bladder 220 13.7 22.6 38.8 37.7 31.8 51.4 14.5 24.5 15.90 16.45
Myeloid leukaemia 100 6.3 12.6 11.3 2.8 14.0 18.3 8.8 10.6 1.98 7.47
Site unknown 269 19.1 21.8 44.2 29.9 61.0 38.2 20.1 38.7 27.62 13.68
aValues of w
2 on 1df (degree of freedom) between lifelong nonsmokers, ex-smokers and continuing smokers and between lifelong nonsmokers and light, moderate and heavy
cigarette smokers.
Table 2 Cause-specific mortality by smoking habit, standardised indirectly for age and study year: cancers uncertainly related to smoking
Mortality per 100000 per year Standardised tests
for trend
(v
2 on 1df)
a Lifelong
nonsmoker
Cigarette smokers, no other habit Other smokers
Former Current
Current, cigarettes per day
Former Current N/X/S Amount
Type of cancer No. of deaths 1–14 15–24 X25
Prostate
b 878 89.4 80.9 90.0 66.7 99.6 113.3 85.9 94.9 0.67 0.52
Colorectal
b 750 52.5 76.1 81.9 73.2 66.6 116.8 81.6 77.7 7.86 14.27
Colon
b 549 41.1 58.6 54.5 57.2 46.6 62.3 63.2 52.2 0.89 1.60
Rectum
b 201 11.3 17.5 27.1 16.3 19.9 53.5 18.3 25.4 14.91 25.99
Colorectal
c 263 81.8 142.1 132.8 195.6 148.8 30.8 159.4 122.1 2.53 0.39
Colon
c 202 61.4 117.3 82.4 120.5 105.3 0.0 126.4 80.1 0.47 0.00
Rectum
c 61 20.4 24.9 51.2 77.1 43.9 30.5 33.1 42.3 4.26 1.38
Rectum
c,d 61 21.4 24.9 46.8 72.3 39.8 27.5 33.7 40.4 3.46 0.01
aValues of w
2 on 1df (degree of freedom) between lifelong nonsmokers, ex-smokers and continuing smokers and between lifelong nonsmokers and light, moderate and heavy
cigarette smokers.
b1951–2001.
c1978–2001.
dAdjusted for alcohol.
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sartefact due to confounding with alcohol. In our data, colorectal
shows some relatively weak relationship with smoking with an
implausibly strong relationship for rectal cancer and no evident
relationship for colon cancer. The apparent limitation of the risk to
rectal cancer may well, however, be largely or wholly due to an
extreme effect of chance, as no such limitation was found in the
many other studies reviewed by the International Agency for
Research on Cancer (2004).
We have data for alcohol consumption for the last 23 years of
the study (1978–2001) and for this period are able to show both
data by smoking habits adjusted for drinking habits (none,
occasional, 1–14 units a week, 15–28 units a week, and 29 or more
units a week) and data by drinking habits, adjusted for smoking
(in both cases the rates are adjusted for 5-year calendar periods; all
other rates are adjusted for single year periods). With the reduced
numbers available for the shorter period of observation (23 years),
fewer of the differences observed are statistically significant. There
continues to be some evidence that rectal, but not colon, cancer is
related to smoking and this persists after adjusting for alcohol
consumption, although the trend is no longer quite statistically
significant. There is, however, no suggestion that it might be
related to alcohol after adjusting for smoking (w2 for trend,
nondrinker, occasional drinker, regular drinker 0.56; for amount
drunk by regular drinker, 0.95).
The reduction in the absolute number of deaths in the later
period is greater than the number expected from the reduction in
the number of years under observation partly because of the
attenuation of the population by death with the passage of time
and partly because the mortality from colorectal cancer in the UK
was progressively reduced over the period of observation (WHO
mortality database, 2004).
Cancers unrelated to smoking
Table 3 shows data similar to those in Table 1 for the relationship
with smoking of 13 of the 14 types of cancer in men that the
Agency was unable to classify because the data were inconsistent
or sparse and also for the group of 13 cancers as a whole. For the
14th type (adrenal cancer), we had no evidence as no death was
attributed to it. For only three types are the numbers substantial
(non-Hodgkin’s lymphoma, cancer of the central nervous system,
and myelomatosis) and for none of them is there the slightest
suggestion that smoking either increases or decreases the risk of
developing the disease. Nor is there any suggestion that smoking
affects the incidence of any of the other types of cancer, for each of
which we have only 50 deaths or fewer, except for Hodgkin’s
lymphoma and thyroid cancer. For the former, there is a weak
suggestion that smoking might be protective (based on 26 deaths),
while for the latter, there is a very weak suggestion that it might be
causative (based on only eight deaths). When, however, so many
tests are applied, some statistically significant results must be
expected to occur by chance. What is more impressive is the lack
of any suggestion of an effect of smoking on this group of cancers
taken as a whole, based on the substantial total of 638 deaths.
CONCLUSION
Data from following up a cohort of male British doctors relating
smoking habits to the risk of 28 types of cancer are generally in
accord with the conclusions of the recent review by the
International Agency for Research on Cancer (2004) and help to
clarify some of the relationships that were uncertain.
For two major types of cancer, the Agency was unable to reach a
conclusion. For one (cancer of the prostate), our data suggest that
it is unlikely to have any material relationship with smoking. For
the other (colorectal cancer), our data confirm a relatively weak
relationship with smoking, which could not be explained by
confounding with the consumption of alcohol.
Data from 12 of the 13 types that occur in men that the Agency
thought were caused by smoking support the conclusion, while
those for 12 of the 13 types for which the Agency had sparse or
inconsistent data suggest, when summed, that no special relation-
ship existed. No data were available for the other two types of
cancer in these two categories (respectively, cancer of the ureter
and cancer of the adrenals).
Table 3 Cause-specific mortality by smoking habit, standardised indirectly for age and study year: cancers for which the evidence has been inconsistent or
sparse
Mortality per 100000 per year Standardised
tests for trend
(v
2 on 1df)
a Lifelong
nonsmoker
Cigarette smokers, no other habit Other smokers
Former Current
Current, cigarettes per day
Former Current N/X/S Amount
Type of cancer No. of deaths 1–14 15–24 X25
Salivary glands 12 1.2 0.4 0.0 0.0 0.0 0.0 0.9 2.6 1.06 1.42
Small intestine 20 2.1 1.3 3.2 3.9 3.3 2.3 3.6 0.7 0.36 0.01
Gallbladder 31 2.8 3.1 3.5 10.0 0.0 0.0 3.2 2.9 0.03 1.98
Soft-tissue sarcoma 20 3.7 0.9 2.4 6.3 0.0 0.0 2.2 1.6 1.25 2.50
Melanoma skin 44 3.8 2.8 6.2 6.4 7.6 3.8 6.0 4.1 0.22 0.63
Nonmelanoma skin 17 2.0 0.8 0.8 0.0 2.3 0.0 2.1 2.4 0.01 0.06
Testis 12 0.5 1.5 1.4 2.7 0.0 1.9 2.1 0.8 0.04 0.96
Central nervous system 125 12.6 15.9 9.7 7.5 8.2 14.1 11.8 11.9 0.67 0.10
Thyroid 8 0.0 1.3 0.7 0.0 0.0 2.7 0.6 1.0 0.98 4.44
Hodgkin’s lymphoma 26 4.4 2.9 0.5 1.4 0.0 0.0 1.4 3.6 2.02
b 7.29
b
Non-Hodgkin’s
lymphoma
175 15.9 15.8 21.1 23.1 29.1 7.0 17.5 18.7 1.13 0.00
Myelomatosis 98 11.3 10.5 10.2 4.9 14.0 10.8 9.9 7.8 1.00 0.04
Lymphatic leukaemia 50 5.8 4.5 6.3 0.0 12.5 4.9 4.2 5.6 0.04 0.26
All above 638 65.9 61.0 62.6 69.2 66.0 49.7 65.5 63.5 0.10 0.62
aValues of w
2 on 1df (degree of freedom) between lifelong nonsmokers, ex-smokers and continuing smokers and between lifelong nonsmokers and light, moderate and heavy
cigarette smokers.
bIn direction of prevention.
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